Related Experiment Video

Updated: Aug 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Hdmx modulates the outcome of p53 activation in human tumor cells

Mark Wade1, Ee Tsin Wong, Mengjia Tang

  • 1Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA.

The Journal of Biological Chemistry
|August 15, 2006
PubMed

Insights

Hdmx protein levels determine cancer cell sensitivity to Nutlin, a drug that reactivates P53. Targeting Hdmx may enhance P53-based cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Wild-type P53 is a tumor suppressor, and its reactivation is a therapeutic strategy.
  • Nutlin activates P53 by inhibiting the Hdm2-P53 interaction.
  • Hdmx, a homolog of Hdm2, also inhibits P53 and may affect Nutlin's efficacy.

Purpose of the Study:

  • To investigate the role of Hdmx in cancer cell sensitivity to Nutlin.
  • To determine if Hdmx expression influences P53 reactivation and apoptosis induction by Nutlin.

Main Methods:

  • Screening of various cancer cell lines for response to Nutlin.
  • Assessing Hdmx levels and Hdmx-P53 complex formation.
  • Using shRNA to reduce Hdmx expression.
  • Evaluating apoptosis induction and caspase-3 involvement.

Main Results:

  • Nutlin reduced Hdmx levels in some cell lines but not others.
  • Nutlin failed to induce apoptosis in cell lines with high Hdmx levels and intact Hdmx-P53 complexes.
  • Reducing Hdmx levels sensitized cells to Nutlin-induced apoptosis.
  • Caspase-3 was not essential for Hdmx degradation or apoptosis.

Conclusions:

  • Hdmx expression is a critical factor in determining the response to Nutlin therapy.
  • Targeting Hdmx could be a complementary strategy to enhance the effectiveness of P53-reactivating drugs like Nutlin.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...